Scientists at Washington University School of Medicine in St. Louis have shown that treating mice with an antibody that blocks the interaction between APOE proteins…
CHICAGO, IL, November 1, 2021 – During National Alzheimer’s Disease Awareness Month and National Family Caregivers Month in November, the Alzheimer’s Association is teaming up with the Ad Council to launch a new national communications…
A brain region critical for memory is smaller in older adults with fewer than 10 teeth than in those who have most of their teeth, suggesting that tooth loss may precede the development of dementia
It has been suggested that blood donors be genetically tested to make sure they don’t have an inherited form of Alzheimer’s, but others think this is unnecessaryBSIP/UIG Via Getty Images
Could Alzheimer’s disease be…
Following publication, the publisher found evidence of peer review manipulation. As the scientific integrity of the article cannot be guaranteed, and in adherence to the recommendations of the Committee on Publication Ethics (COPE),…
NEW YORK, NY, March 29, 2023 – The Ad Council, in partnership with the Alzheimer’s Association and NASCAR, launched new public service announcements (PSAs) featuring NASCAR driver Ryan Blaney sharing his family’s journey with…
NEW YORK, NY, March 29, 2023 – The Ad Council, in partnership with the Alzheimer's Association and NASCAR, launched new public service announcements (PSAs) featuring NASCAR driver Ryan Blaney sharing his family's journey with Alzheimer's…
1 Introduction
Alzheimer’s Disease (AD), the most prevalent form of dementia among the elderly (Mckhann et al., 1984), entails irreversible neurodegeneration. Progressive decline in cognitive abilities and memory deterioration are…
SEATTLE--(BUSINESS WIRE)-- #AGBT2024--NanoString Technologies, Inc. (OTC: NSTGQ), a leading provider of life science tools for discovery and translational research, today announced that research using the company’s CosMx™ Spatial…
NEW YORK, NY, August 16, 2023 – The Ad Council, in partnership with the Alzheimer’s Association and creative agency Lopez Negrete Communications, launched new public service advertisements (PSAs) “Some Things Come with Age” in an effort…
1 Introduction
The number of people living with dementia was estimated to be 55 million in 2019 and is expected to increase to 139 million by 2050 (International, ASD, 2022). With an aging population, the economic burden and caregiver…
Why This Matters
Neurodegenerative diseases such as Alzheimer’s and Parkinson’s can make day-to-day tasks challenging because they may affect cognitive, motor, and social function. Neurodegenerative diseases affect about 7 million…
On the surface, the movement disorder amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, and the cognitive disorder frontotemporal lobar degeneration (FTLD), which underlies frontotemporal…
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a leading provider of ultra-sensitive research products and high-definition diagnostics, today announced a specific partnership path for laboratories interested in…
1 Introduction
In 195 countries worldwide, there has been a significant increase in the advanced-age population, mainly as a result of substantial population growth (Chang et al., 2019). By 2050, 20% of the global population will be…
1 Introduction
Alzheimer’s disease (AD), typically embodied by dysmnesia, language deficits, cognitive bewilderment and behavioral anomalies, is a progressive neurodegenerative condition that unfolds gradually, worsening over time and…
1 Introduction
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by cognitive impairment, along with mental and behavioral abnormalities, and a decline in the ability to perform daily activities. It is the most…
Adjusted poverty headcount ratio for the equal indicator weighting structure stratified by dementia status alone (no, mild, moderate to severe cognitive impairment…
A molecule found in the keto diet plays a key role in preventing early memory decline in mice. The memory loss is comparable to mild cognitive impairment in the…
Representative immunofluorescence images of human frontal cortex adjacent to the tissue used in snRNA-seq experiments stained for microglia marker IBA1 (green),…
Illustration of the study design. Three proteomics platforms were used to analyze proteomics from three different biofluids in multiple cohorts Inset within each…
Illinois graduate student Yeeun Yook, left, and professor Nien-Pei Tsai worked with their team to find the earliest marker of Alzheimer’s disease yet reported in…
(A) Representative images and quantification of Aβ stained with thioflavin S in the hippocampus and cortex of 5xFAD mice treated with or without APC. (B) Radial arm…
Large Aβ Agg MCI patients display lower AD-like brain pathology than large Aβ Agg MCI. a 18F-FTP PET uptake in each group at baseline, two-year follow-up, and…
Researchers identify a mutation that alters Alzheimer’s disease progression. The UMA coordinates this study, carried out by 100 multidisciplinary researchers from 50 different entities. Credit: University…
Researchers identify a mutation that alters Alzheimer’s disease progression. The UMA coordinates this study, carried out by 100 multidisciplinary researchers from 50 different entities. Credit: University…
Researchers identify a mutation that alters Alzheimer's disease progression. The UMA coordinates this study, carried out by 100 multidisciplinary researchers from…
On Jan. 31, aducanumab, a pricey drug approved for treatment of early-stage Alzheimer’s disease, was withdrawn from the market. And in early March, the Food and Drug Administration delayed its decision regarding whether to approve a…
On Jan. 31, aducanumab, a pricey drug approved for treatment of early-stage Alzheimer's disease, was withdrawn from the market. And in early March, the Food and Drug Administration delayed its decision regarding whether to approve…
Various changes are seen in the brains of people with Alzheimer’s, but the exact cause of the disease is unclearScience Photo Library/Alamy
A new understanding of Alzheimer’s disease suggests that the root cause…
David Vaillancourt, Ph.D., (left) is a senior author on a new study linking abnormal amyloid in the blood with brain changes on diffusion MRI. Credit: University of…
Instead of approving the new Alzheimer’s drug donanemab this month, as was expected, the United States. Food and Drug Administration will now require the experimental medication be scrutinized more closely by an expert…
Instead of approving the new Alzheimer's drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication…
Studies at MIT and elsewhere are producing mounting evidence that light flickering and sound clicking at the gamma brain rhythm frequency of 40 hertz (Hz) can reduce Alzheimer’s disease (AD) progression and treat…
Some cancer treatments cause what is known as chemo brain, generally defined as memory and concentration problemsWangbar/Alamy
An experimental treatment for Alzheimer’s disease that involves flickering lights and…
Some cancer treatments cause what is known as chemo brain, generally defined as memory and concentration problems
Wangbar/Alamy
An experimental treatment for Alzheimer’s disease that involves flickering lights and low-pitched…
Some cancer treatments cause what is known as chemo brain, generally defined as memory and concentration problemsWangbar/Alamy
An experimental treatment for Alzheimer’s disease that involves flickering lights and…
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by memory loss and cognitive decline. There is emerging evidence that the pathogenesis of neurodegeneration is related to widespread and progressive…
1 Introduction
Artificial intelligence's (AI) success in aiding medical diagnosis and treatment depends mainly on the publicly available diverse datasets. Many publicly available biomedical datasets are small and stem from relatively…